Could CBD cure psoriasis and eczema? Researchers believe it is possible after recent trials on CBD’s effect on skin conditions.
Eight million people in the United States suffer from psoriasis and 31 million suffer from eczema. Together, they make up 11 percent of America’s population.
Psoriasis is a long-lasting autoimmune disease that causes raised, red, itchy, dead skin patches to appear on the skin. Eczema is very similar but can normally be cleared with topical treatment. Psoriasis, on the other hand, has no known cure. However, some topicals can keep the symptoms in remission.
Scientists from the University of Colorado believe that cannabidiol (CBD) could be the next wave of psoriasis and eczema treatment. Some people claim that CBD has helped with their inflammatory conditions. CBD naturally contains anti-inflammatory properties and is known to help those with arthritis and chronic pain. But can it help those with inflammatory skin conditions?
Researchers, led by Dr. Robert Dellavalle, began experiments on Parkinson’s patients with seborrheic dermatitis- a common skin condition that typically forms scaly patches, red skin, and dandruff on the scalp. The trials for the CBD-based pill have yet to finish, but they believe their studies could be showing a relation between CBD and psoriasis/eczema patients. Dr. Dellavalle said that there is a large percentage of the population that don’t like using steroids, even if they are topical steroids on their skin. “This [CBD] would be an alternative, natural product for them to try.” He also believes there is potential for CBD to work for patients who don’t receive results from their topical steroids.
Common treatments for psoriasis and eczema are corticosteroid creams which have side effects- significantly, permanent scarring. Countless patients have resorted to extreme raw food dieting and fasting but have to keep up with those measures to keep their symptoms at bay.
Dr. Robert Dellavalle said it could be years before their specialized CBD pill would be available. It is extremely difficult to conduct studies, formulate, and gain approval for medical CBD research in the United States due to the scheduling of marijuana under the Controlled Substance Act.
Marijuana is currently listed as a Schedule I substance- the same schedule as meth, heroin, and LSD. Schedule I substances are defined as drugs that have a high potential for abuse and have no currently accepted medical use.
Hemp-derived CBD is available legally in the United States, for the time being. Laws and regulations in states, counties, and cities are constantly fluctuating, causing a lot of confusion for consumers and patients. While a formal medical test has yet to be completed, many eczema and psoriasis patients have made the switch to CBD oils and topical creams and have seen great results.
It is a hope for eczema and psoriasis patients that they can gain the benefits of CBD without having to wait years to eventually get a prescription for a possibly synthetic copy.